Upstream Bio, Inc.

NasdaqGS:UPB Stock Report

Market Cap: US$327.2m

Upstream Bio Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

E. Sutherland

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure1yr
CEO ownershipn/a
Management average tenure1yrs
Board average tenure2.8yrs

Recent management updates

No updates

Recent updates

Upstream Bio: Treating Respiratory Disorders With TSLP Targeting Differentiation

Dec 16

Upstream Bio: Attractive, But Let's Wait For More Data And Lock-Up Expiry

Dec 07

CEO

E. Sutherland (53 yo)

1yr

Tenure

Dr. E. Rand Sutherland, MD, MPH, has been a Director of Krystal Biotech, Inc. from January 2022. Dr. Sutherland serves as Chief Executive Officer and Director at Upstream Bio, Inc. since April 2024. Dr. Su...

Leadership Team

NamePositionTenureCompensationOwnership
Aaron Deykin
Chief Medical Officer and Head of Research & Development3yrsUS$823.24k0%
$ 0
E. Sutherland
CEO & Director1yrno datano data
Michael Gray
CFO & COO1.1yrsno datano data
Parika Petaipimol
Head of Technical Operationsno datano datano data
Allison Ambrose
General Counselless than a yearno datano data
Lisa Fiering
Senior Vice President of People & Culture1yrno datano data
Adam Houghton
Chief Business Officer3.5yrsno datano data
Mersedeh Miraliakbari
Senior Vice President of Regulatory Affairs & Quality2.5yrsno datano data
Fang Xie
VP & Head of Biometrics2.3yrsno datano data
Sumathi Sivapalasingam
VP & Head of Clinical Developmentless than a yearno datano data
Maryse Courval
VP, Head of Clinical Operations & Head of Medical Writingless than a yearno datano data
William Collins
Secretaryno datano datano data

1.0yrs

Average Tenure

53.5yo

Average Age

Experienced Management: UPB's management team is not considered experienced ( 1 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
E. Sutherland
CEO & Director1yrno datano data
Erez Chimovits
Independent Director3.5yrsno datano data
Ronald Renaud
Independent Chairman of the Board3.4yrsUS$208.22k0%
$ 0
Liam Ratcliffe
Independent Director3.5yrsno datano data
Daniella Beckman
Independent Directorno datano datano data
H. Fleming
Independent Director1.8yrsno datano data
Marcella Ruddy
Independent Director2.2yrsUS$185.33k0%
$ 0

2.8yrs

Average Tenure

60yo

Average Age

Experienced Board: UPB's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/04/07 22:34
End of Day Share Price 2025/04/07 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Upstream Bio, Inc. is covered by 4 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tessa RomeroJ.P. Morgan
Yasmeen RahimiPiper Sandler Companies
Yaron WerberTD Cowen